4,4',4''-(4-PROPYL-(1H)-PYRAZOLE-1,3,5-TRIYL)TRISPHENOL for leptospirosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Apr 2024: Trial started, NCT07127718
  2. 17 Aug 2025: Trial registered, NCT07127718

The trials

NCT07127718: Preventive Strategies for Early and Late Complications of Leptospirosis

State
Under way
Phase
Phase 2
People
678 planned
Started
12 Apr 2024
Primary completion
Mar 2027
Arms
Prophylactic Plasma Component Therapy with Conventional Treatment (PPTTRT)
Results
None posted
  1. 12 Apr 2024: Trial started
  2. 17 Aug 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Also known as Prophylactic Plasma Transfusion.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.